Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Patrick Yung Chih Wen, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Patrick Wen and Jay Loeffler.
Patrick Wen
Connection Strength
2.098
Jay Loeffler
  1. Brain metastases. Curr Treat Options Oncol. 2000 Dec; 1(5):447-58.
    View in: PubMed
    Score: 0.239
  2. Management of brain metastases. Oncology (Williston Park). 1999 Jul; 13(7):941-54, 957-61; discussion 961-2, 9.
    View in: PubMed
    Score: 0.217
  3. High-grade astrocytomas. Neurol Clin. 1995 Nov; 13(4):875-900.
    View in: PubMed
    Score: 0.168
  4. Advances in the diagnosis and management of pituitary tumors. Curr Opin Oncol. 1995 Jan; 7(1):56-62.
    View in: PubMed
    Score: 0.159
  5. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer. 1994 Jun 15; 73(12):3029-36.
    View in: PubMed
    Score: 0.153
  6. Stereotactic radiosurgery treats intracranial lesions. Diagn Imaging (San Franc). 1994 May; 16(5):76-80, 107.
    View in: PubMed
    Score: 0.152
  7. Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia. 1999 Mar; 40(3):341-4.
    View in: PubMed
    Score: 0.053
  8. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg. 1999 Jan; 90(1):72-7.
    View in: PubMed
    Score: 0.052
  9. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. J Neurooncol. 2019 Mar; 142(1):69-77.
    View in: PubMed
    Score: 0.052
  10. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017 11; 15(11):1331-1345.
    View in: PubMed
    Score: 0.048
  11. Central Nervous System Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Oct; 13(10):1191-202.
    View in: PubMed
    Score: 0.042
  12. Radiosurgery for Intracranial Malignancies. Semin Radiat Oncol. 1995 Jul; 5(3):225-234.
    View in: PubMed
    Score: 0.041
  13. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 1995 Feb; 36(2):275-82; discussion 282-4.
    View in: PubMed
    Score: 0.040
  14. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995 Jan 04; 87(1):34-40.
    View in: PubMed
    Score: 0.040
  15. Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Nov; 12(11):1517-23.
    View in: PubMed
    Score: 0.039
  16. Increased perfusion due to vascular normalization improves oxygenation and survival in glioblastoma patients treated with cediranib with or without chemoradiation. Neuro Oncol. 2014 Jul; 16 Suppl 3:iii12.
    View in: PubMed
    Score: 0.038
  17. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):19059-64.
    View in: PubMed
    Score: 0.037
  18. Central nervous system cancers. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1114-51.
    View in: PubMed
    Score: 0.036
  19. Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology. 1993 Jun; 43(6):1111-4.
    View in: PubMed
    Score: 0.036
  20. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med. 1993 Feb; 94(2):216-9.
    View in: PubMed
    Score: 0.035
  21. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol. 1992 Sep; 10(9):1379-85.
    View in: PubMed
    Score: 0.034
  22. Development of Lhermitte's sign after bone marrow transplantation. Cancer. 1992 May 01; 69(9):2262-6.
    View in: PubMed
    Score: 0.033
  23. Central nervous system cancers. J Natl Compr Canc Netw. 2011 Apr; 9(4):352-400.
    View in: PubMed
    Score: 0.031
  24. Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst. 1990 Dec 19; 82(24):1918-21.
    View in: PubMed
    Score: 0.030
  25. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1455-62.
    View in: PubMed
    Score: 0.030
  26. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23.
    View in: PubMed
    Score: 0.029
  27. The effects of irradiation on major histocompatibility complex expression and lymphocytic infiltration in the normal rat brain and the 9L gliosarcoma brain tumor model. J Neuroimmunol. 1990 May; 27(2-3):239-44.
    View in: PubMed
    Score: 0.029
  28. Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. Radiother Oncol. 1990 Apr; 17(4):311-21.
    View in: PubMed
    Score: 0.029
  29. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol. 1990 Apr; 8(4):576-82.
    View in: PubMed
    Score: 0.029
  30. Phase Ib study of cediranib in combination with daily temozolomide and radiation in patients with newly diagnosed glioblastoma. J Clin Oncol. 2009 May 20; 27(15_suppl):e13010.
    View in: PubMed
    Score: 0.027
  31. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007 Jan; 11(1):83-95.
    View in: PubMed
    Score: 0.023
  32. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002 Jun 01; 53(2):394-400.
    View in: PubMed
    Score: 0.017
  33. Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones. J Neuropathol Exp Neurol. 2000 Dec; 59(12):1044-50.
    View in: PubMed
    Score: 0.015
  34. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol. 2000 Feb; 18(4):708-15.
    View in: PubMed
    Score: 0.014
  35. Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery. 1998 Mar; 42(3):446-53; discussion 453-4.
    View in: PubMed
    Score: 0.012
  36. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. Int J Radiat Oncol Biol Phys. 1998 Jan 01; 40(1):65-70.
    View in: PubMed
    Score: 0.012
  37. A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas. Clin Cancer Res. 1997 Mar; 3(3):381-7.
    View in: PubMed
    Score: 0.012
  38. A phase I study of etanidazole and radiotherapy in malignant glioma. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):617-20.
    View in: PubMed
    Score: 0.010
  39. Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study. Int J Radiat Oncol Biol Phys. 1992; 22(3):577-80.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.